Background {#Sec1}
==========

Distal radius fractures (DRF) are a common type of orthopedic fracture that results from falls in elderly individuals \[[@CR1]--[@CR3]\]. As the life span of the general population has increased, so has the incidence of DRF in the elderly \[[@CR4]\]. While the incidence of hip and shoulder fractures increases after the age of 80, the incidence of DRFs increases at age 60--70 and therefore affects more active elderly individuals \[[@CR5]\]. Lee et al. \[[@CR6]\] previously reported that patients with DRF do not have significantly lower average lean body mass but that bone mineral density (BMD) is significantly lower in patients with DRF. Some reports have suggested that low body mass is a risk for hip fracture \[[@CR7], [@CR8]\] and that patients with DRF have a preserved body mass compared with patients with hip fracture. Optimal treatment strategies appropriate for different types of DRFs and patient categories are currently a subject of debate. Not only has the overall rate of surgically managed fractures increased, there has also been a significant increase in the use of internal plate fixation \[[@CR9]\]. Reduced physical activity due to pain, impaired function, and fear of falling after fall-associated DRF likely increases future fall risk by decreasing the effectiveness of protective responses via the deterioration of muscular strength, balance, and reaction time \[[@CR10]\]. In addition, elderly patients tend to have developed polypharmacy to treat multiple diseases, and it has been reported that polypharmacy is a risk factor for falls \[[@CR11]\]. The frequency of adverse drug reactions has been shown to increase when six or more drugs are prescribed, and the frequency of falls among outpatients increases when five or more drugs are prescribed. Maki et al. investigated the effect of polypharmacy on the occurrence of hip fractures in patients who took five or more oral medications and reported that patients experienced longer hospital stays and had decreased Barthel Index (BI) efficiency, relative to those taking fewer drugs \[[@CR12]\]. Potentially inappropriate medications (PIMs) are a major concern in geriatric care. PIMs increase the risk of falls, emergency department visits, and unplanned hospitalizations in elderly patients. Masumoto et al. \[[@CR13]\] reported that 32.3% of elderly people with chronic diseases use PIMs, and PIMs and polypharmacy increase the risk of falls.

However, no reports have investigated the effects of polypharmacy or PIMs on the rates of DRF, despite the fact DRFs among the elderly often occur as a result of falls. Therefore, identification of unnecessary and potentially hazardous drugs among DRF patients will be useful for improving patient outcomes. Further, despite the high risk of PIM administration among these patients, the effects of treatment on activities of daily living (ADL) and adverse events have not been investigated. Therefore, the aim of the present study was to assess the association between PIMs and subsequent falls in elderly patients with DRF.

Methods {#Sec2}
=======

Study design and participants {#Sec3}
-----------------------------

This retrospective cohort study involved 253 patients aged 65 years or older that were admitted to an acute care hospital for surgical treatment of DRF between October 2014 and December 2018, and who were followed-up for at least 1 year post-surgery. Patients were retrospectively identified via a surgical database search that encompassed two affiliated hospitals. Demographic and postoperative clinical course information was extracted from each patient's electronic medical record. Patients with neurological/cognitive impairment, multiple fractures, death, and missing data, including bone density information, post-spine surgery were excluded. Ethical approval was obtained from each hospital's ethics board. Patient informed consent was waived due to the retrospective design of the study.

Surgical treatment and rehabilitation {#Sec4}
-------------------------------------

A volar locking plate was used for internal fixation in all cases (ACU-LOC plate, ACUMED, LLC., USA, *n* = 96 cases; Anatomic Volar Plate System, Depuy Synthes, Johnson & Johnson. Co., USA, *n* = 81 cases; Stellar2, HOYA Technosurgical Co., Japan, *n* = 47 cases; and APUTUS 2.5, Medical engineering system Co., Japan, *n* = 29 cases). Surgery was performed in all cases with a brachial plexus block. A standard volar approach was used to expose the fractured side. The fracture was approached from the radial side of the flexor carpi radialis, and the quadrate pronator muscle was incised to reduce the fracture. If the fracture was unstable, it was reduced with a Kirschner wire. Following surgery, all patients were casted for 3--7 days depending on the stability of the fracture site. Throughout postoperative rehabilitation, finger excursion training was initiated 1 day post-operation. Active and passive training of the wrist joint with one-on-one guidance began after cast removal. The rehabilitation period was defined as the 5 months that followed surgery. Evaluations were carried out by performing periodic medical examinations after the rehabilitation period had ended.

Measurements {#Sec5}
------------

Data including patient age, sex, body mass index, total number of medicines used at admission, number and type of PIMs used at admission, bone mineral density (as a percentage of the mean among young adults), use of drugs for osteoporosis, fracture type, serum albumin level, comorbidity severity (Charlson Comorbidity Index \[CCI\]), BI, BI gain, Mayo score, length of hospital stay, and occurrence of subsequent falls were reviewed for each patient. Osteoporosis was defined as a *T*-score less than and equal to − 2.5 SD at L2--4 lumber vertebrae. Fracture type was classified using the AO/OTA classification system. This classification system is commonly used for the radiographic classification of DRF into the following three categories: A, B, and C. Category A includes extra-articular fractures, B includes intra-articular fractures, and C contains intra-articular complete fractures \[[@CR14]\]. Comorbidity was assessed using the CCI \[[@CR15]\]. CCI is an indicator of multi-disease comorbidities and includes diabetes with chronic complications, heart failure, kidney disease, liver disease, chronic lung disease, dementia, hemiplegia or paraplegia, malignancy, and AIDS/HIV. The CCI uses a weighted score for each comorbidity, with higher numbers indicating a greater number of comorbidities and greater risk of mortality. ADL were evaluated using BI scores. BI scores are determined through an assessment of 10 features: eating, moving, dressing, toilet movement, bathing, walking, going up and down stairs, changing clothes, defecation, and urination. Each item is scored as follows: 0, unable to complete; 1, needs help; or 2, independent. Total scores are multiplied by 20, to produce a maximum score of 100. ADL scores were assessed both before surgery and at the final follow-up appointment. BI gains were determined by subtracting preoperative BI from BI scores at the end of follow-up. The Mayo wrist score was used to evaluate wrist function. This score ranges from 0 to 100 points, and greater scores indicate increased function. The score incorporates pain scores, functional status, range of motion, and grip strength. Two criteria for PIMs are used globally: Beers criteria \[[@CR16]\] and the Screening Tool of Older Persons' Prescriptions (STOPP) \[[@CR17]\]. In Japan, the Screening Tool for Older Persons' Appropriate Prescriptions for Japanese (STOPP-J) is used \[[@CR18]\]. Therefore, we used STOPP-J to classify PIMs in this study. PIMs were used if patients were taking STOPP-J drugs at the time of admission and continued to take the drugs 1 year after surgery.

Regarding the measurement of outcomes, the primary outcome considered was the occurrence of subsequent fall(s), and the secondary outcome considered was BI gain.

Statistical analysis {#Sec6}
--------------------

For statistical analysis, the patients were divided into two groups: those who used PIMs and those who did not. The unpaired *t* test, Mann-Whitney's *U* test, and *χ*2 test were used to perform comparisons between groups depending on variables assessed and the normality of data. In addition, propensity score matching was carried out. Propensity scores were calculated using age, sex, CCI, fracture type, and Mayo wrist score. Variance inflation factor (VIF) was calculated as an index of multicollinearity, and items with VIF values of 2 or less were used as independent variables. Spearman's rank correlation was used for the univariate analysis. A multiple linear regression analysis after propensity score matching was performed to assess BI gain. Data were analysed using SPSS version 25 (IBM Corporation; Armonk, NY, USA).

Results {#Sec7}
-------

The study included 253 patients aged 65 years or older that were admitted to an acute care hospital for surgical treatment of DRF between October 2014 and December 2018, who were followed-up for at least 1-year post-surgery. Three cases involving neurological/cognitive impairment, two cases involving multiple fractures, 1 case in which the patient had died, and 15 cases that lacked necessary data were excluded from the study (Fig. [1](#Fig1){ref-type="fig"}). The subjects were divided into two groups: a PIM use group and a PIM non-use group. One hundred and seven cases (42.3%) were prescribed PIMs. Significant differences (*p* \< 0.05) between the two groups were observed regarding fracture type, serum albumin level, CCI, length of hospital stay, and fall rate. Propensity score (PS) was calculated from age, sex, fracture type, CCI, and Mayo score. After PS matching, 107 cases within the PIM use group and 146 from the PIM non-use group were assessed (Table [1](#Tab1){ref-type="table"}). Univariate analysis after PS matching revealed that the two groups significantly differed with regard to CCI, number of drugs used upon admission, BI gain, and subsequent fall rate. No significant difference was observed between the two groups with regard to the occurrence of surgical complications after DRF (Table [2](#Tab2){ref-type="table"}). The types and distribution of PIMs are shown in Table [3](#Tab3){ref-type="table"}. The three most frequently prescribed STOPP-J PIMs were hypotonics (24.2%), NSAIDS (16.8%), and diuretics (12.1%). Spearman's rank correlation results are shown in Table [4](#Tab4){ref-type="table"}. PIM use positively correlated with CCI, total number of drugs used at admission, and fall rate during follow-up periods and negatively correlated with BI gain. Results of multivariate analysis of BI gain after propensity score matching are shown in Table [5](#Tab5){ref-type="table"}. The number of PIMs significantly affected the BI gain (PIMs, *β* = − 0.181; 95% CI, − 1.589 to − 0.196; *p* = 0.012). The results of the logistic regression analysis are shown in Table [6](#Tab6){ref-type="table"}. The incidence of subsequent falls was correlated with the number of PIMs (odds ratio, 0.108; 95% CI, 1.246 to 2.357; *p* \< 0.001). Fig. 1Flow-chart of patients selectionTable 1Demographic and clinical characteristics before and after matchingCharacteristicsAll patients (*n* = 253)Propensity-matched patients (*n* = 191)PIMs use group (*n* = 107)PIM non-use group (*n* = 146)*p*PIMs use group (*n* = 107)PIMs non-use group (*n* = 84)*p*Age (year)75.6 ± 8.672.8 ± 7.70.114^1)^75.6 ± 8.673.4 ± 7.70.112^1)^Sex, female93 (86.6)124 (85.3)0.718^2)^93 (86.6)72 (81.6)0.395^2)^Fracture type, *n* (%)0.019^2)^0.110^2)^ AO type A10 (9.3)3 (2.1)10 (9.3)2 (2.2) Type B42 (39.3)52 (35.6)42 (39.3)40 (46.0) Type C55 (51.4)91 (62.3)55 (51.4)42 (48.3)BMI (kg/m^2^)22.4 ± 3.722.2 ± 3.80.842^1)^22.4 ± 3.722.2 ± 3.60.561^1)^Serum albumin (g/dl)4.03 ± 0.444.09 ± 0.32\< 0.001^1)^4.03 ± 0.444.07 ± 0.320.326^1)^BMD (g/cm^2^)0.89 ± 0.150.89 ± 0.150.921^1)^0.89 ± 0.150.89 ± 0.140.476^1)^CCI0.57 ± 0.700.57 ± 0.70\< 0.001^1)^0.57 ± 0.700.30 ± 0.570.01^1)^Total number of drugs administered on admission5.45 ± 2.725.45 ± 2.720.178^1)^5.45 ± 2.723.41 ± 2.62\< 0.001^1)^Use of drugs for osteoporosis, *n* (%)20 (18.7)22 (15.1)0.444^2)^20 (18.7)12 (14.3)0.418^2)^Length of hospital stay2.29 ± 2.061.76 ± 0.890.006^1)^2.29 ± 2.061.83 ± 0.910.061^1)^BI score Admission77.2 ± 7.8977.8 ± 6.080.059^1)^77.2 ± 7.8977.3 ± 6.410.720^1)^ 1 year after surgery85.3 ± 9.0387.4 ± 8.290.747^1)^85.3 ± 9.0387.3 ± 8.750.117^1)^BI gain9.66 ± 5.808.04 ± 4.940.183^1)^9.66 ± 5.8010.0 ± 5.600.006^1)^Mayo wrist score 1 year after surgery83.1 ± 6.7284.7 ± 6.400.060^1)^83.1 ± 6.7284.7 ± 6.400.132^1)^Subsequent falls, *n* (%)24 (22.4)13 (8.9)0.003^2)^24 (22.4)7 (8.0)0.009^2)^Values are presented as mean ± standard, deviation or number (%), or median (interquartile range)*PIMs* potentially inappropriate medications, *BMI* body mass index, *BMD* body mineral density, *CCI* Charlson Comorbidity Index, *BI* Barthel Index^1)^Student *t* test^2)^Chi-squared testTable 2Postoperative complications of DRF after matchingComplicationsAll (***n*** = 191)PIMs non-use (***n*** = 84)PIMs use (***n*** = 107)***p*** value0.559^1)^EPL rupture1 (0.5)0 (1.3)1 (0.9)Screw loosening1 (0.5)0 (0)1 (0.9)Compression7 (3.6)2 (2.2)5 (4.7)Neuropathy3 (1.5)2 (2.2)1 (0.9)Values are presented as number (%)*PIMs* potentially inappropriate medications, *EPL* extensor pollicis longus^1)^Chi-squared testTable 3Types and frequency of potentially inappropriate medications as pharmacotherapyPIMs (drug class or generic names)Patients (%)Hypnotics26 (24.2)NSAIDs18 (16.8)Diuretics13 (12.1)Antipsychotics8 (7.4)Oral antidiabetic drugs8 (7.4)H~2~ receptor antagonist7 (6.5)Antithrombotic drugs5 (4.7)Laxative (magnesium oxide)3 (2.8)Overactive bladder medications3 (2.8)Steroids3 (2.8)H~1~ receptor antagonist (first generation)2 (1.9)Alpha-blockers2 (1.9)Antidepressants2 (1.9)Sulpiride1 (0.9)Beta-blockers1 (0.9)Antiparkinson drug1 (0.9)Digitalis0Insulin0Antiemetic drugs0Table 4Spearman's rank coefficients among different factors after matchingAge (year)BMI (kg/m^2^)Serum albumin (g/dl)PIMsTotal number of drugs administered on admissionCCIBI at admissionBI at 1 year after surgeryBI gainFall during follow-up periodsAge (year)10.053− 0.213^\*\*^0.156^\*\*^0.292^\*\*^0.060− 0.147^\*^− 0.128− 0.0510.165^\*^BMI (kg/m2)10.213^\*\*^0.0330.0990.0090.1400.155^\*^0.077− 0.070Serum albumin (g/dl)1− 0.052− 0.227^\*\*^− 0.209^\*\*^0.362^\*\*^0.598^\*\*^0.472^\*\*^− 0.393^\*\*^PIMs10.469^\*\*^0.255^\*\*^− 0.050− 0.140− 0.168^\*^0.223^\*\*^Total number of drugs administered on admission10.423^\*\*^− 0.146^\*^− 0.210^\*\*^− 0.165^\*^0.185^\*\*^CCI1− 0.134− 0.275^\*\*^− 0.277^\*\*^0.269^\*\*^BI at admission10.677^\*\*^− 0.064− 0.157^\*^BI at 1 year after surgery10.650^\*\*^− 0.223^\*\*^BI gain1− 0.208^\*\*^Fall during follow-up periods1*BMI* body mass index, *PIMs* potentially inappropriate medications, *CCI* Charlson Comorbidity Index, *BI* Barthel Index\**p* \< 0.05\*\**p* \< 0.01Table 5Liner regression analysis for BI gain after matchingVariables***β***95% confidence interval***p*** valueLowerUpperPS9.6808.70910.650\< 0.001PIMs− 0.181− 1.589− 0.1960.012PS (log-transformed propensity score) was calculated from log transformation of the propensity score for age, sex, Charlson Comorbidity Index, fracture type, and Mayo wrist score*PIMs* potentially inappropriate medicationsTable 6Logistic regression analysis for subsequent fall after matchingVariablesOdds ratio95% confidence interval***p*** valueLowerUpperPS1.7130.001PIMs0.1081.2462.357\< 0.001PS (log-transformed propensity score) was calculated from log transformation of the propensity score for age, sex, Charlson Comorbidity Index, fracture type, and Mayo wrist score*PIMs* potentially inappropriate medications

Discussion {#Sec8}
==========

This retrospective cohort study revealed two major findings regarding PIM use among elderly patients that experienced DRF. First, the prevalence of PIM prescriptions was determined to be 42.3%. Second, the number of PIMs prescribed may increase risk of subsequent falls post-DRF. To the best of our knowledge, this is the first study to determine characteristics of PIM use and assess the occurrence of subsequent falls in elderly patients with DRF.

Chukwulebe et al. \[[@CR19]\] and Akkawi et al. \[[@CR20]\] reported PIM use rates of 28.7% and 28.5%, respectively, among elderly individuals. On the other hand, Huang et al. \[[@CR21]\] reported that 67.3% of patients receiving home care use PIMs. To define PIMs, some past reports, including one authored by Chukwulebe et al., used Beers criteria to define PIMs, while Akkawi et al. used STOPP/START, and Huang et al. used STOPP-J criteria. PIM use in the study by Huang et al. was determined to be higher than in other studies because the authors investigated elderly patients with comorbid conditions that had received home-based medical services. Additionally, PIMs categorized via STOPP-J criteria are associated with hospitalization and mortality in Japanese patients receiving home-based medical services. Our results indicate that the rate of PIM use is greater than rates determined by Chukwulebe et al. and Akkawi et al. The increased PIM use determined by this study is likely due to the inclusion of patients admitted to acute care hospitals with multiple specialty departments, and with other comorbidities. As a result, patients often received prescriptions from multiple departments, so the usage rate of PIMs was likely elevated. We used STOPP-J in this study to classify PIMs. STOPP-J is a clinical practice guideline and consensus statement for standard care of Japanese elderly patients \[[@CR18]\]. A systematic review based on clinical questions and keywords determined these recommendations via the GRADE (grading of recommendations assessment, development, and evaluation) approach \[[@CR21]\]. Beers criteria include drugs not used in Japan \[[@CR16]\], and the STOPP criteria predict hospitalizations associated with inappropriate prescriptions \[[@CR17]\]. STOPP-J is a scientifically based drug list that uses a systematic review and GRADE system to determine recommendations and evaluates the safety of drugs that may be less common in elderly individuals \[[@CR22]\]. We used STOPP-J criteria because this study was conducted in elderly patients. STOPP-J criteria consist of a list of drugs that require particularly careful administration and a list of drugs that should be considered for treatment.

In this study, we were able to show that the number of PIMs prescribed was associated with the increased occurrence of subsequent falls. Regarding the relationship between PIMs and falls, Early et al. \[[@CR23]\] reported that falls among geriatric patients were associated with the use of one or more PIMs. Nakamichi et al. \[[@CR24]\] determined that antipsychotic drug use was positively associated with the risk of falls, and 6.1% of patients who experienced a hip fracture used antipsychotics. In the present study, patients used hypnotics (*n* = 26), antipsychotics (*n* = 8), and antidepressants (*n* = 2). Further, 3.1% of all patients and 7.4% of those using PIMs used antipsychotics. These rates were higher than those reported by Nakamichi et al. \[[@CR24]\]; however, this could possibly be explained by the nature of our acute care general hospital, which treats a large number of patients with multiple diseases that are at increased risk of experiencing anxiety and insomnia. The results also suggest that the use of PIMs may have a greater effect on subsequent falls in DRF patients than in hip fracture patients.

Of the 34 patients with subsequent falls, the PIMs use group reported one vertebral fracture, one hip fracture, and 22 bruises, and the PIMs non-use group reported one clavicle fracture, one acute subdural hematoma, and 11 bruises. There were no cases of re-fracture or transposition at the site operated on for DRF.

Regarding the effect of PIMs on BI gain, there was initially no significant difference in BI gain of DRF between the two groups, but there was a significant difference in BI gain between the two groups after propensity score matching. Moreover, multiple linear regression analysis showed that PIMs influenced BI gain, and a negative correlation was observed between BI gain and PIM use. These findings indicate that ADL acquisition tends to decrease with increased PIM use. The number of PIMs showed a positive correlation with CCI, suggesting that increased PIM use may interfere with ADL acquisition in patients experiencing multiple morbidities. In this study, age, serum album, PIMs, BI, and CCI were identified as factors associated with subsequent falls. In addition, logistic regression analysis using propensity score matching to assess the probability of experiencing subsequent falls revealed that PIM use enhanced the probability of experiencing subsequent falls. Early et al. \[[@CR23]\] examined the risk factors of falls in elderly individuals and found that age and number of PIMs increased the fall risk. They indicated that antipsychotics, antidepressants, psychotic medicines, opioids, and neuropathic medicines were drugs that enhanced the risk of falling. The study reported that the numbers of patients who repeatedly experienced falls after taking hypnotics, NSAIDS, and both hypnotics and NSAIDS were 10, 8, and 6, respectively. Although the types of PIMs differed from those reported by Early et al., the results of the present study suggest that the number of PIMs, in addition to the type of PIMs prescribed, may influence the occurrence of falls. After propensity score matching, there was a significant difference in the total number of medications used in the comparison of the two groups, and it was considered necessary to reduce the number of drugs in order to reduce PIMs. The results of this study show how increasing the awareness of health care staff in terms of risk factors for PIMs, and improving patient education, may increase ADL and prevent subsequent falls in patients with DRF.

This study had a few limitations. First, detailed patient data, including sarcopenia, muscle strength, and pain assessment were lacking due to the retrospective study design. Second, motor function after DRF and its association with PIMs were not assessed using the timed up and go test, or balance test. The Mayo wrist score was not significantly different from PIMs use in this study. However, there was a significant difference between the two groups in terms of fracture type, and it is necessary to examine the relationship between wrist joint function, fracture type, PIMs, and other influencing factors by increasing the number of databases analysed, thereby improving the power of the study.

Conclusion {#Sec9}
==========

This study revealed that the number of PIMs prescribed affected ADL after DRF and increased the risk of experiencing subsequent falls. Therefore, appropriate PIM management at admission and the incorporation of fall prevention programs are important for improving outcomes in elderly DRF patients.
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